Dr. Timothy Rebbeck is the Vincent L. Gregory Professor of Cancer Prevention at the Harvard T.H. Chan School Of Public Health and Professor of Medical Oncology at Dana-Farber Cancer Institute. Professor Rebbeck also serves as the director for the Zhu Family Center for Global Cancer Prevention Harvard TH Chan School of Public Health and the Center for Cancer Equity and Engagement at Dana Farber Harvard Cancer Center. Professor Rebbeck’s research focuses on the etiology and prevention of cancer, with an emphasis on cancer disparities and global health. He has directed large, multicenter studies and international consortia that have identified genetic, molecular, and epidemiological factors associated with cancer risk, outcomes, and disparities. He leads the international Men of African Descent and Carcinoma of the Prostate (MADCaP) network and has led a number of consortia studying hereditary cancer risk and prevention.
Ensuring equity in precision oncology
Novel technologies in precision oncology offer great promise for improved cancer screening, early detection, treatment, and monitoring. However, it is well known that the introduction of novel technologies can create or exacerbate health disparities. Forethought and planning are needed to ensure precision tools lead to equity in health.
Russ Cucina, UCSF